{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:52Z","timestamp":1793126032872,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005629","name":"Takeda Pharmaceuticals USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001127","name":"Genentech Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014489","name":"Johnson & Johnson Pharmaceutical Research and Development LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejps.2026.107691","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:09:46Z","timestamp":1792166986000},"page":"107691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Translational evaluation of in vitro-to-in vivo extrapolation techniques for brain penetration using open flow microperfusion and microdialysis in rats"],"prefix":"10.1016","volume":"227","author":[{"given":"Yukiko","family":"Murata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janita","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1497-3140","authenticated-orcid":false,"given":"Zubida M.","family":"Al-Majdoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"De Bruyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9531-9505","authenticated-orcid":false,"given":"Thomas","family":"Altendorfer-Kroath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis E.C.A.","family":"Hop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Turski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Zientek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Neuhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Birngruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Galetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Rostami-Hodjegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2446-6895","authenticated-orcid":false,"given":"Kayode","family":"Ogungbenro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107691_bib0001","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","article-title":"Proteomic quantification of human blood\u2013brain barrier SLC and ABC transporters in healthy individuals and dementia patients","volume":"16","author":"Al-Majdoub","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107691_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107022","article-title":"Transporter expressions as part of required scaling factor to support in vitro in vivo extrapolation for blood-brain barrier drug permeability","volume":"209","author":"Al-Majdoub","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107691_bib0003","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/bdd.2343","article-title":"In vivo monitoring of brain pharmacokinetics and pharmacodynamics with cerebral open flow microperfusion","volume":"44","author":"Altendorfer-Kroath","year":"2023","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2026.107691_bib0004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jneumeth.2018.09.024","article-title":"Comparison of cerebral Open Flow microperfusion and microdialysis when sampling small lipophilic and small hydrophilic substances","volume":"311","author":"Altendorfer-Kroath","year":"2019","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejps.2026.107691_bib0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/pharmaceutics6010097","article-title":"Development of a physiologically-based pharmacokinetic model of the rat central nervous system","volume":"6","author":"Badhan","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107691_bib0006","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/mp400533q","article-title":"A physiologically based modeling strategy during preclinical CNS drug development","volume":"11","author":"Ball","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107691_bib0007","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1002\/jps.23266","article-title":"Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone","volume":"101","author":"Ball","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107691_bib0008","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/1440-1681.12174","article-title":"Cerebral open flow microperfusion: a new in vivo technique for continuous measurement of substance transport across the intact blood-brain barrier","volume":"40","author":"Birngruber","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejps.2026.107691_bib0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ddtec.2016.07.003","article-title":"Cerebral open flow microperfusion (cOFM) an innovative interface to brain tissue","volume":"20","author":"Birngruber","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejps.2026.107691_bib0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/cpt.2643","article-title":"Clinical implications of altered drug transporter abundance\/function and PBPK modeling in specific populations: an ITC perspective","volume":"112","author":"Chu","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107691_bib0011","series-title":"Microdialysis in Drug Development","first-page":"13","article-title":"Recovery and calibration techniques: toward quantitative microdialysis","author":"de Lange","year":"2013"},{"key":"10.1016\/j.ejps.2026.107691_bib0012","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/dmd.107.017434","article-title":"Vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system","volume":"36","author":"Feng","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107691_bib0013","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-4682-6-2","article-title":"Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination","volume":"6","author":"Fenneteau","year":"2009","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.ejps.2026.107691_bib0014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41573-023-00877-1","article-title":"Membrane transporters in drug development and as determinants of precision medicine","volume":"23","author":"Galetin","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2026.107691_bib0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.dmpk.2016.03.005","article-title":"Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: estimating time varying CSF drug concentrations and their variability using in vitro data","volume":"31","author":"Gaohua","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107691_bib0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2016.03.021","article-title":"The need for new approaches in CNS drug discovery: why drugs have failed, and what can be done to improve outcomes","volume":"120","author":"Gribkoff","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejps.2026.107691_bib0017","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/dmd.105.007211","article-title":"Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: k(p), K(p,u), and K(p,uu)","volume":"34","author":"Gupta","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107691_bib0018","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1208\/s12248-017-0108-2","article-title":"Microdialysis as an important technique in systems pharmacology\u2014a historical and methodological review","volume":"19","author":"Hammarlund-Udenaes","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2026.107691_bib0019","series-title":"Drug Delivery to the Brain: Physiological Concepts, Methodologies and Approaches","author":"Hammarlund-Udenaes","year":"2014"},{"key":"10.1016\/j.ejps.2026.107691_bib0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejpb.2012.07.020","article-title":"Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models","volume":"82","author":"Hellinger","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107691_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2026.107486","article-title":"Application of modelling of cell monolayer permeation data to generate input parameters compatible with in vitro-in vivo translation of blood-brain-barrier disposition of drugs","volume":"220","author":"Hogan","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107691_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.60","article-title":"Cerebral open flow microperfusion to monitor drug transport across the blood-brain barrier","volume":"85","author":"Hummer","year":"2019","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107691_bib0023","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1124\/jpet.111.180398","volume":"339","author":"Kodaira","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2026.107691_bib0024","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tips.2006.04.004","article-title":"Using positron emission tomography to facilitate CNS drug development","volume":"27","author":"Lee","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2026.107691_bib0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/cpt.2021","article-title":"Physiologically based pharmacokinetic modeling of Central nervous system pharmacokinetics of CDK4\/6 inhibitors to guide selection of drug and dosing regimen for brain cancer treatment","volume":"109","author":"Li","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107691_bib0026","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1158\/1078-0432.CCR-17-0983","article-title":"Quantitative and mechanistic understanding of AZD1775 penetration across Human blood-brain barrier in glioblastoma patients using an IVIVE-PBPK modeling approach","volume":"23","author":"Li","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2026.107691_bib0027","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s11095-022-03246-6","article-title":"Unbound brain-to-plasma partition coefficient, kp,uu,brain\u2014A game changing parameter for CNS drug discovery and development","volume":"39","author":"Loryan","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107691_bib0028","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/pharmaceutics16020226","article-title":"Interspecies brain PBPK modeling platform to predict passive transport through the blood-brain barrier and assess target site disposition","volume":"16","author":"Mehta","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107691_bib0029","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1208\/s12248-021-00675-w","article-title":"In vitro to In vivo extrapolation linked to physiologically based pharmacokinetic models for assessing the brain drug disposition","volume":"24","author":"Murata","year":"2022","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2026.107691_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.dmpk.2015.10.003","article-title":"Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(-\/-) rats","volume":"31","author":"Nagaya","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107691_bib0031","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ddtec.2021.06.002","article-title":"Application of proteomic data in the translation of in vitro observations to associated clinical outcomes","volume":"39","author":"Neuhoff","year":"2021","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejps.2026.107691_bib0032","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/bja\/aes216","article-title":"<em>In vivo<\/em>microdialysis in pharmacological studies of antibacterial agents in the brain","volume":"109","author":"Notkina","year":"2012","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejps.2026.107691_bib0033","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12967-020-02313-z","article-title":"The endless frontier? The recent increase of R&D productivity in pharmaceuticals","volume":"18","author":"Pammolli","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejps.2026.107691_bib0034","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/pharmaceutics14061283","article-title":"A historical review of brain drug delivery","volume":"14","author":"Pardridge","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107691_bib0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(24)00476-9","article-title":"Crossing the blood-brain barrier: emerging therapeutic strategies for neurological disease","volume":"24","author":"Pedder","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejps.2026.107691_bib0036","series-title":"Animal Models for the Study of Human Disease","first-page":"569","article-title":"Chapter 24 - animal models and methods to study the relationships between brain and tissues in metabolic regulation","author":"Penicaud","year":"2013"},{"key":"10.1016\/j.ejps.2026.107691_bib0037","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12987-023-00497-2","article-title":"Methodological and analytical considerations for intra-operative microdialysis","volume":"20","author":"Riviere-Cazaux","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ejps.2026.107691_bib0038","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17425247.2024.2306138","article-title":"Blood-brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics","volume":"21","author":"Ronaldson","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2026.107691_bib0039","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/clpt.2012.65","article-title":"Physiologically based pharmacokinetics joined with In vitro-In vivo extrapolation of ADME: a marriage under the arch of systems pharmacology","volume":"92","author":"Rostami-Hodjegan","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107691_bib0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","article-title":"Physiologically-based pharmacokinetics in drug development and regulatory science","volume":"51","author":"Rowland","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2026.107691_bib0041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/pharmaceutics13010095","article-title":"Impact of CNS diseases on drug delivery to brain extracellular and intracellular target sites in human: a \"WHAT-IF\" simulation study","volume":"13","author":"Saleh","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107691_bib0042","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/pharmaceutics13060834","article-title":"Expression and function of organic anion transporting polypeptides in the human brain: physiological and pharmacological implications","volume":"13","author":"Sch\u00e4fer","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107691_bib0043","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0003-2670(98)00598-4","article-title":"Methods and issues in microdialysis calibration","volume":"379","author":"Stenken","year":"1999","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejps.2026.107691_bib0044","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.107.121525","article-title":"Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction","volume":"322","author":"Summerfield","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2026.107691_bib0045","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/psp4.70010","article-title":"Evaluation of Adefovir PBPK model to assess biomarker-informed OAT1 drug\u2013Drug interaction and effect of chronic kidney disease","volume":"14","author":"Tan","year":"2025","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107691_bib0046","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/jpet.111.184200","volume":"339","author":"Uchida","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2026.107691_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007117","article-title":"Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis","volume":"15","author":"Verscheijden","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejps.2026.107691_bib0048","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1208\/s12248-012-9366-1","article-title":"Physiologically based pharmacokinetic modeling to investigate regional brain distribution kinetics in rats","volume":"14","author":"Westerhout","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2026.107691_bib0049","first-page":"765","article-title":"Predicting drug concentration-time profiles in multiple CNS compartments using a comprehensive physiologically-based pharmacokinetic model","volume":"6","author":"Yamamoto","year":"2017","journal-title":"CPT: Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107691_bib0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11095-016-2065-3","article-title":"A generic multi-compartmental CNS distribution model structure for 9 drugs allows prediction of human brain target site concentrations","volume":"34","author":"Yamamoto","year":"2017","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:53:07Z","timestamp":1793123587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":50,"alternative-id":["S0928098726002654"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107691","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational evaluation of in vitro-to-in vivo extrapolation techniques for brain penetration using open flow microperfusion and microdialysis in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107691"}}